The FDA is hoping that smokers who are unable to quit will eventually move to non-combustible tobacco products, which so far seem to carry fewer health risks
Though several policies provide exceptions for syringe possession, the burden of proof remains on the person who uses drugs to provide a defense recognized as permissible in that state (e.g., identify themselves as an SSP participant, show syringes were received from a public health entity, or demonstrate syringes are for personal use or disease prevention)
* Data included in this article has been taken from documents published by the WHO (2017)
The evidence is compelling: The 2025 Cochrane review confirms nicotine e-cigarettes outperform NRT for cessation Sweden has reached smoke-free status 15 years ahead of the EU's 2040 target The UK's Swap to Stop programme sees close to two thirds of participants successfully quit Modelling suggests up to 355,000 lives could be saved annually if harm reduction approaches were adopted EU-wide We've made 10 specific recommendations to the Commission, covering differential taxation, flavour policy, youth protection, labelling, and more
2nd Sign requirement: Tobacco retailers must post, in a conspicuous manner and place, a sign or signs indicating that the sale of tobacco products or hemp products intended for smoking to any person under 21 years of age is prohibited by law
